The immunological barriers to xenotransplantation

Critical Reviews in Immunology

Volumn 16, Issue 4, 1996, Pages 331-358

  Platt, Jeffrey L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

accommodation; acute vascular xenograft rejection; complement; endothelium; hyperacute rejection; natural antibodies

Indexed keywords

ANTIBODY; COMPLEMENT;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; COMPLEMENT ACTIVATION; GRAFT REJECTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; NONHUMAN; ORGAN DONOR; PATHOPHYSIOLOGY; PHYLOGENY; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; XENOTRANSPLANTATION;

ANIMALS; GRAFT REJECTION; HUMANS; SPECIES SPECIFICITY; TRANSPLANTATION, HETEROLOGOUS;

EID: 0029906950     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (191)

1. Nowak, R., Xenotransplants set to resume, Science, 266, 1148, 1994.
2. Hoke, F., As cross-species transplantation forges ahead, some researchers call for caution, The Scientist, 9, 1, 1995.
3. Platt, J. L. and Logan, J. S., Use of transgenic animals in xenotransplantation, Submitted, 1995.
4. Sandrin, M. S., Fodor, W. L., Mouhtouris, E., Osman, N., Cohney, S., Rollins, S. A., Guilmette, E. R., Setter, E., Squinto, S. P., and McKenzie, I., Enzymatic remodelling of the carbohydrate surface of a xenogeneic cell substantially reduces human antibody binding and complement-mediated cytolysis, Nature Med., 1, 1261, 1995.
5. Platt, J. L., Hyperacute Xenograft Rejection, R.G. Landes Company, Austin, TX, 1995.
6. Ullman, E., Tissue and organ transplantation, Ann. Surg., 60, 195, 1914.
7. Carrel, A., Transplantation in mass of the kidneys, J. Exp. Med., 10, 98, 1908.
8. Carrel, A., The transplantation of organs, N.Y. J. Medicine, 99, 839, 1914.
9. Guthrie, C. C., Blood-Vessel Surgery and its Applications, Longmans, Green & Co., New York, NY, 1912.
10. Reemtsma, K., McCracken, B. H., Schlegel, J. U., Pearl, M. A., Pearce, C. W., DeWitt, C. W., Smith, P. E., Hewitt, R. L., Flinner, R. L., and Creech, O., Renal heterotransplantation in man, Ann. Surg., 160, 384, 1964.
11. Starzl, T. E., Marchioro, T. L., Peters, G. N., Kirkpatrick, C. H., Wilson, W. E. C., Porter, K. A., Rifkind, D., Ogden, D. A., Hitchcock, C. R., and Waddell, W. R., Renal heterotransplantation from baboon to man: experience with 6 cases, Transplantation, 2, 752, 1964.
12. Jooste, S. V., Colvin, R. B., and Winn, H. J., The vascular bed as the primary target in the destruction of skin grafts by antiserum, J. Exp. Med., 154, 1332, 1981.
13. Platt, J. L., Vercellotti, G. M., Dalmasso, A. P., Matas, A. J., Bolman, R. M., Najarian, J. S., and Bach, F. H., Transplantation of discordant xenografts: a review of progress. Immunol. Today, 11, 450, 1990.
14. Chopek, M. W., Simmons, R. L., and Platt, J. L., ABO incompatible renal transplantation: initial immunopathologic evaluation, Transpl. Proc., 19, 4553, 1987.
15. Bromberg, B. E., Song, I. C., and Mohn, M. P., The use of pig skin as a temporary biological dressing, Plast. Reconstr. Surg., 36, 80, 1965.
16. Auchincloss, H. Jr., Xenogeneic transplantation, Transplantation, 46, 1, 1988.
17. Egdahl, R. H., Good, R. A., and Varco, R, L., Studies in homograft and heterograft survival, Surgery. 42, 228, 1957.
18. Pierson, R. N., Winn, H. J., Russell, P. S., and Auchincloss, H., Xenogeneic skin graft rejection is especially dependent on CD4+ T cells, J. Exp. Med., 170, 991, 1989.
19. Winn, H. J., Baldamus, C. A., Jooste, S. V., and Russell, P. S., Acute destruction by humoral antibody of rat skin grafted to mice: The role of complement and polymorphonuclear leukocytes, J. Exp. Med., 137, 893, 1973.
20. Baldamus, C. A., McKenzie, I. F., Winn, H. J., and Russell, P. S., Acute destruction by humoral antibody of rat skin grafted to mice, J. Immunol., 110, 1532, 1973.
21. Sykes, M., Asentijevich, I., Sharabi, Y., and Sachs, D. H., Xenotolerance through bone marrow transplantation, in Xenotransplantation: The Transplantation of Organs and Tissues Between Species, Cooper, D. K. C., Ejvind, K., Reemtsma, K., and White, J. G., Eds., Springer-Verlag, New York, NY, 1991, 121-138.
22. Gritsch, H. A., Glaser, R. A., Lee, L. A., Emery, D. W., Smith, C. V., Sablinski, T., Arn, J. S., Sachs, D. H., and Sykes, M., Non-immune factors resisting reconstitutions by discordant xenogeneic hematopoietic cells, Transpl. Proc., (In Press), 1994.
23. Calne, R. Y., Organ transplantation between widely disparate species, Transpl. Proc., 2, 550, 1970.
24. Perper, R. J. and Najarian, J. S., Experimental renal heterotransplantation. II. Closely related species, Transplantation, 4, 700, 1966.
25. Shah, A. S., Itescu, S., O'Hair, D. P., Tugulea, S., Kwiatkowski, P. A., Liu, Z., Platt, J. L., Rose, E. A., Suciu-Foca, N., and Michler, R. E., Immunologic evaluation following concordant heart xenotransplantation in splenectomized primates, Submitted, 1995.
26. Burdick, J. F., Russell, P. S., and Winn, H. J., Sensitivity of long-standing xenografts of rat hearts to humoral antibodies, J. Immunol., 123, 1732, 1979.
27. Schuurman, H.-J., Joergensen, J., Kuipers, H., Lardelli, P., White, D., and Schreier, M., Vascular transplantation of syrian hamster heart into lewis rat: effect of brequinar, cyclosporine, cobra venom factor and splenectomy, Transpl. Proc., 26, 1217, 1994.
28. Bollinger, R. R., Fabian, M. A., Harland, R. C., Murray, W. J., Baldwin, W. M. III, Abernethy, K., Britt, L., Sontag, M., and Halperin, E. C., Total lymphoid irradiation for cardiac xenotransplantation in nonhuman primates, Transpl. Proc., 23, 587, 1991.
29. Perper, R. J. and Najarian, J. S., Experimental renal heterotransplantation. I. In widely divergent species, Transplantation, 4, 377, 1966.
30. Platt, J. L., Antibodies in graft rejection, in Transplantation Immunology, Bach, F. H. and Auchincloss, H., Eds., Wiley-Liss, Inc., New York, NY. 1995, 113-129.
31. Calne, R. Y., White, H. J. O., Herbertson, B. M., Millard, P. R., Davis, D. R., Salaman, J. R., and Samuel, J. R., Pig-to-baboon liver xenografts, Lancet. 1, 1176, 1968.
32. Gordon, R. D., Iwatsuki, S., Esquivel, C. O., Tzakis, A., Todo, S., and Starzl, T. E., Liver transplantation across ABO blood groups, Surgery, 100, 342, 1986.
33. Collins, B. H., Chari, R. S., Magee, J. C., Harland, R. C., Lindman, B. J., Logan, J. S., Bollinger, R. R., Meyers, W. C., and Platt, J. L., Mechanisms of injury in porcine livers perfused with blood of humans with fulminant hepatic failure, Transplantation, 58, 1162, 1994.
34. Kaplon, R. J., Platt, J. L., Kwiatkowski, P. A., Edwards, N. M., Xu, H., Shah, A. S., and Michler, R. E., Absence of hyperacute rejection in pig-to-primate orthotopic pulmonary xenografts, Transplantation, 59, 410, 1995.
35. Cotterell, A. H., Collins, B. H., Parker, W., Harland, R. C., and Platt, J. L., The humoral immune response in humans following cross-perfusion of porcine organs. Transplantation, 60, 861, 1995.
36. Collins, B. H., Cotterell, A. H., McCurry, K. R., Alvarado, C. G., Magee, J. C., Parker, W., and Platt, J. L., Cardiac xenografts between primate species provide evidence for the importance of the α-galactosyl determinant in hyperacute rejection, J. Immunol., 154, 5500, 1995.
37. Parker, W., Saadi, S., Lin, S. S., Holzknecht, Z. E., Bustos, M., and Platt, J. L., Transplantation of discordant xenografts: a challenge revisited, Immunol. Today, 17, 373, 1996.
38. Lawson, J. H. and Platt, J. L., Molecular barriers to xenotransplantation, Transplantation, in press, 1996.
39. Stephenson, J., Xenotransplantation workshop ponders science, safety of animal tissue grafts, JAMA, 274, 286, 1995.
40. Edwards, J., Complement activation by xenogeneic red blood cells, Transplantation, 31, 226, 1981.
41. Platt, J. L., Vercellotti, G. M., Lindman, B, J., Oegema, T. R. Jr., Bach, F. H., and Dalmasso, A. P., Release of heparan sulfate from endothelial cells: implications for pathogenesis of hyperactute rejection, J. Exp. Med., 171, 1363, 1990.
42. Horstmann, R. D., Pangburn, M. K., and Müller-Eberhard, H. J., Species specificity of recognition by the alternative pathway of complement, J. Immunol., 134, 1101, 1985.
43. Moses, R. D. and Auchincloss, H. Jr., Mechanism of cellular xenograft rejection, in Xenotransplantation. The Transplantation of Organs and Tissues Between Species, Cooper, D. K. C., Kemp, E., Reemtsma, K., and White, D. J. G., Eds., Springer-Verlag, New York, NY, 1991, 101-120.
44. Rose, A. G., Histopathology of cardiac xenograft rejection, in Xenotransplantation. The Transplantation of Organs and Tissues Between Species, Cooper, D. K. C., Kemp, E., Reemtsma, K., and White, D. J. G., Eds., Springer-Verlag, New York, NY, 1991, 231-242.
45. Larsen, S. and Starklint, H., Histopathology of kidney xenograft rejection, in Xenotransplantation. The Transplantation of Organs and Tissues Between Species, Cooper, D. K. C., Kemp, E., Reemtsma, K., and White, D. J. G., Eds., Springer-Verlag, New York, NY, 1991, 181-206.
46. Tze, W. J., Tai, J., and Cheung, S., Human islet xenograft survival in diabetic rats - a functional and immunohistochemical study, Transplantation, 49, 502, 1990.
47. Mayer, M. M., Complement and complement fixation, in Experimental Immunochemistry, Charles C Thomas, Springfield, IL, 1961, 133.
48. Giles, G. R., Boehmig, H. J., Lilly, J., Amemiya, H., Takagi, H., Coburg, A. J., Hathaway, W. E., Wilson, C. B., Dixon, F. J., and Starzl, T. E., Mechanism and modification of rejection of heterografts between divergent species, Transpl. Proc., 2, 522, 1970.
49. Rose, A. G., Cooper, D. K. C., Human, P. A., Reichenspurner, H., and Reichart, B., Histopathology of hyperacute rejection of the heart: experimental and clinical observations in allografts and xenografts, J. Heart Lung Transplant., 10, 223, 1991.
50. Forbes, R. D. C., Kuramochi, T., Guttmann, R. D., Klassen, J., and Knaack, J., A controlled sequential morphologic study of hyperacute cardiac allograft rejection in the rat. Lab. Inv., 33, 280, 1975.
51. Busch, G. J., Martins, A. C. P., Hollenberg, N. K., Wilson, R. E., and Colman, R. W., A primate model of hyperacute renal allograft rejection, Am. J. Pathol., 79, 31, 1975.
52. Colman, R. B., Habal, M., Hollenberg, N. K., Birtch, A. G., and Busch, G. J., Hyperacute renal allograft rejection in the primate, Am. J. Pathol., 82, 25, 1976.
53. Platt, J. L., Xenotransplantation, in Handbook of Transplant Immunology, Fogarty, P. Bucks, Ed., Medical and Scientific Productions, United Kingdom, 1995, 259-299.
54. Perper, R. J. and Najarian, J. S., Experimental renal heterotransplantation. III. Passive transfer of transplantation immunity, Transplantation, 5, 514, 1967.
55. Platt, J. L., Fischel, R. J., Matas, A. J., Reif, S. A., Bolman, R. M., and Bach, F. H., Immunopathology of hyperacute xenograft rejection in a swine-to-primate model, Transplantation, 52, 214, 1991.
56. Leventhal, J. R., Matas, A. J., Sun, L. H., Reif, S., Bolman, R. M. III, Dalmasso, A. P., and Platt, J. L., The immunopathology of cardiac xenograft rejection in the guinea pig to rat model, Transplantation, 56, 1, 1993.
57. Platt, J. L., Turman, M. A., Noreen, H. J., Fischel, R. J., Bolman, R. M., and Bach, F. H., An ELISA assay for xenoreactive natural antibodies, Transplantation, 49, 1000, 1990.
58. Saadi, S., Ihrcke, N. S., and Platt, J. L., Pathophysiology of xenograft rejection, in Principles of Immunomodulatory Drug Development in Transplantation and Autoimmunity, Lieberman, R. and Morris, R., Eds., Raven Press, New York, NY, 1995.
59. Matas, A. J., Sibley, R., Mauer, M., Sutherland, D. E. R., Simmons, R. L., and Najarian, J. S., The value of needle renal allograft biopsy, Ann. Surg., 197, 226, 1983.
60. Alexandre, G. P. J., Gianello, P., Latinne, D., et al., Plasmapheresis and splenectomy in experimental renal xenotransplantation, in Xenograft 25, Hardy, M. A., Ed., Eisevier Science Publishers, New York, NY, 1989, 259-266.
61. Alexandre, G. P. J., Squifflet, J. P., De Bruyere, M., Latinne, D., Reding, R., Gianello, P., Carlier, M., and Pirson, V., Present experiences in a series of 26 ABO-incompatible living donor renal allografts, Transpl. Proc., 19, 4538, 1987.
62. Palmer, A., Welsh, K., Gjorstrup, P., Taube, D., Bewick, M., and Thick, M., Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation, Lancet, 1, 10, 1989.
63. Ross, C. N., Gaskin, G., Gregor-MacGregor, S., Patel, A. A., Davey, N. J., Leghler, R. I., Williams, G., Rees, A. J., and Pusey, C. D., Renal transplantation following immunoadsorption in highly sensitized recipients, Transplantation, 55, 785, 1993.
64. Wecker, H., Winn, H. J., and Auchincloss, H., CD4+ T cells, without CDS+ or b lymphocytes, can reject xenogeneic skin grafts, Xenotransplantation, 1, 8, 1994.
65. Alter, B. J. and Bach, F. H., Cellular basis of the proliferative response of human T cells to mouse xenoantigens, J. Exp. Med., 191, 333, 1990.
66. Geller, R. L., Turman, M. A., Dalmasso, A. P., and Platt, J. L., The natural immune barrier to xenotransplantation. JASN, 3, 1189, 1993.
67. Yamada, K., Sachs, D. H., and DerSimonian, H., Human anti-porcine xenogeneic T cell response. Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition, J. Immunol., 155, 5249, 1995.
68. Batten, P., Heaton, T., Fuller-Espie, S., and Lechler, R, I., Human anti-mouse xenorecognition, The American Association of Immunologists, 155, 1057, 1995.
69. Gewurz, H., Clark, D. S., Finstad, J., Kelly, W. D., and Varco, R. L., Role of the complement system in graft rejections in experimental animals and man, Ann. N.Y. Acad. Sci., 129, 673, 1966.
70. Gewurz, H., Clark, D. S., Cooper, M. D., Varco, R. L., and Good, R. A., Effect of cobra venom-induced inhibition of complement activity on allograft and xenograft rejection reactions, Transplantation, 5, 1296, 1967.
71. Chartrand, C., O'Regan, S., Robitaille, P., and Pinto-Blonde, M., Delayed rejection of cardiac xenografts in C6-deficient rabbits, J. Immunol., 38, 245, 1979.
72. Leventhal, J. R., Dalmasso, A. P., Cromwell, J. W., Platt, J. L., Manivel, C. J., Bolman, R. M., and Matas, A. J., Prolongation of cardiac xenograft survival by depletion of complement, Transplantation, 55, 857, 1993.
73. Pruitt, S. K., Kirk, A. D., Bollinger, R. R., Marsh, H. C. Jr., Collins, B. H., Levin, J. L., Mault, J. R., Heinle, J. S., Ibrahim, S., Rudolph, A. R., Baldwin, W. M. III, and Sanfilippo, F., The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts, Transplantation, 57, 363,1994.
74. Brauer, R. B., Baldwin, W. M. III, Daha, M. R., Pruitt, S. K., and Sanfilippo, F., Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts, J. Immunol., 151, 7240, 1993.
75. McCurry, K. R., Kooyman, D. L., Alvarado, C. G., Cotterell, A. H., Martin, M. J., Logan, J. S., and Platt, J. L., Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury, Nature Medicine, 1, 423, 1995.
76. Platt, J. L. and Bach, F. H., The barrier to xenotransplantation, Transplantation, 52, 937, 1991.
77. Parker, W., Bruno, D., and Platt, J. L., Xenoreactive natural antibodies in the world of natural antibodies: Typical or Unique? Transplant Immunology, 3, 181, 1995.
78. Clark, D. S., Gewurz, H., Good, R. A., and Varco, R. L., Complement fixation during homograft rejection, Surg. Forum, 15, 144, 1964.
79. Kissmeyer-Nielsen, F., Olsen, S., Petersen, V. P., and Fjeldborg, O., Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells, Lancet, ii, 662, 1966.
80. Boyden, S. V., Natural antibodies and the immune response, Adv. Immunol., 5, 1, 1964.
81. Hammer, C., Preformed natural antibodies (PNAB) and possibilities of modulation of hyperacute xenogeneic rejection (HXAR), Transpl. Proc., 21, 522, 1989.
82. Johnston, P. S., Wang, M.-W., Lim, S. M. L., Wright, L. J., and White, D. J. G., Discordant xenograft rejection in an antibody-free model, Transplantation, 54, 573, 1992.
83. Miyagawa, S., Hirose, H., Shirakura, R., Naka, Y., Nakata, S., Kawashima, Y., Seya, T., Matsumoto, M., Uenaka, A., and Kitamura, H., The mechanism of discordant xenograft rejection, Transplantation, 46, 825, 1988.
84. Johnston, P., Lim, S., Wright, L., and White, D., Hyperacute xenograft rejection takes place in the complete absence of antibodies but requires the presence of functional complement, Transpl. Proc., 23, 877, 1991.
85. Muller-Eberhard, H. J., Molecular organization and function of the complement system, Annu. Rev. Biochem., 57, 321, 1988.
86. Cooper, D. K. C., Human, P. A., Lexer, G., Rose, A. G., Rees, J., Keraan, M., and Du Toit, E., Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon, J. Heart Transpl., 7, 238, 1988.
87. Kaplon, R. J., Michler, R. E., Xu, H., Kwiatkowski, P. A., Edwards, N. M., and Platt, J. L., Absence of hyperacute rejection in newborn pig-to-baboon cardiac xenografts, Transplantation, 59, 1, 1994.
88. Dalmasso, A. P., Vercellotti, G. M., Fischel, R. J., Bolman, R. M., Bach, F. H., and Platt, J. L., Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients, Am. J. Pathol., 140, 1157, 1992.
89. Platt, J. L. and Holzknecht, Z. E., Porcine platelet antigens recognized by human xenoreactive natural antibodies, Transplantation, 57, 327, 1994.
90. Holzknecht, Z. E. and Platt, J. L., Identification of porcine endothelial cell membrane antigens recognized by human xenoreactive antibodies, J. Immunol., 154, 4565, 1995.
91. Parker, W. R., Bruno, D., Holzknecht, Z. E., and Platt, J. L., Xenoreactive natural antibodies: isolation and initial characterization, J. Immunol., 153, 3791, 1994.
92. Dalmasso, A. P., Vercellotti, G. M., Platt, J. L., and Bach, F. H., Inhibition of complement-mediated endothelial cell cytotoxicity by decay accelerating factor: potential for prevention of xenograft hyperacute rejection, Transplantation, 52, 530, 1991.
93. Pangburn, M. K., Schreiber, R. D., and Muller-Eberhard, H. J., Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria, Proc. Natl. Acad. Sci. U.S.A., 80, 5430, 1983.
94. Nicholson-Weller, A., March, J. P., Rosenfeld, S. I., and Austen, F., Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor, Proc. Natl. Acad. Sci. U.S.A., 80, 5066, 1983.
95. Buchberg, A. M., Brownell, E., Nagata, S., Jenkins, N. A., and Copeland, N., A comprehensive genetic map of murine chromosome 11 reveals extensive linkage conservation between mouse and human, Genetics, 122, 153, 1989.
96. Atkinson, J. P., Oglesby, T. J., White, D., Adams, E. A., and Liszewski, M. K., Separation of self from non-self in the complement system: a role for membrane cofactor protein and decay accelerating factor, Clin. Exp. Immunol., 86 (Suppl. 1), 27, 1991.
97. Byrne, G. W., McCurry, K. R., Martin, M. J., McClellan, S. M., Platt, J. L., and Logan, J. S., Expression of human CD59 and DAF in transgenic pigs: intrinsic regulation of complement activity, Transplantation, in press, 1996.
98. Inverardi, L., Samaja, M., Motterlini, R., Mangili, F., Bender, J. R., and Pardi, R., Early recognition of a discordant xenogeneic organ by human circulating lymphocytes, J. Immunol., 149, 1416, 1992.
99. Lanier, L. L. and Phillips, J. H., Inhibitory MHC class I receptors on nk cells and t cells, Immunol. Today, 17, 86, 1996.
100. Blakely, M. L., Van Der Werf, W. J., Berndt, M. C., Dalmasso, A. P., Bach, F. H., and Hancock, W. W., Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection, Transplantation, 58, 1059, 1994.
101. Platt, J. L., Lindman, B. J., Geller, R. L., Noreen, H. J., Swanson, J. L., Dalmasso, A. P., and Bach, F. H., The role of natural antibodies in the activation of xenogenic endothelial cells, Transplantation, 52, 1037, 1991.
102. Platt, J. L., Dalmasso, A. P., Lindman, B. J., Ihrcke, N. S., and Bach, F. H., The role of C5a and antibody in the release of heparan sulfate from endothelial cells, Eur. J. Immunol., 21, 2887, 1991.
103. Magee, J. C., Platt, J. L., Oldham, K. T., and Guice, K. S., Oxidant stress increases suceptibility of porcine endothelial cells to injury by xenoreactive antibodies and complement, Transpl. Proc., 26, 1170, 1994.
104. Good, A. H., Cooper, D. K. C., Malcolm, A. J., Ippolito, R. M., Koren, E., Neethling, F. A., Ye, Y., Zuhdi, N., and Lamontagne, L. R., Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans, Transpl. Proc., 24, 559, 1992.
105. Sandrin, M. S., Vaughan, H. A., Dabkowski, P. L., and McKenzie, I. F. C., Anti-pig IgM antibodies in human serum react predominantly with Galα(1,3)Gal epitopes, Proc. Natl. Acad. Sci. U.S.A., 90, 11391, 1993.
106. Collins, B. H., Parker, W. R., and Platt, J. L., Characterization of porcine endothelial cell determinants recognized by human natural antibodies, Xenotransplantation, 1, 36, 1994.
107. Neethling, F. A., Koren, E., Ye, Y., Richards, S. V. Kujundzic, M., Oriol, R., and Cooper, D. K. C., Protection of pig kidney (PK15) cells from the cytotoxic effect of anti-pig antibodies by α-galactosyl oligosaccharides, Transplantation, 57, 959, 1994.
108. Galili, U., Rachmilewitz, E. A., Peleg, A., and Flechner, I., A unique natural human IgG antibody with anti-α-galactosyl specificity, J. Exp. Med., 160, 1519, 1984.
109. Galili, U., Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: a major obstacle for xenotransplantation in humans, Immunol.Today, 14, 480, 1993.
110. Galili, U., Clark, M. R., Shohet, S. B., Buehler, J., and Macher, B. A., Evolutionary relationship between the natural anti-Gal antibody and the Gal α1-3Gal epitope in primates, Proc. Natl. Acad. Sci. U.S.A., 84,1369, 1987.
111. Parker, W., Lundberg-Swanson, K. L., Holzknecht, Z. E., Lateef, J., Washburn, S. A., Braedehoeft, S. J., and Platt, J. L., Isohemagglutinins and xenoreactive antibodies: members of a distinct family of natural antibodies, Hum. Immunol., 45, 94, 1996.
112. Collins, B. H., Cotterell, A. H., McCurry, K. R., Alvarado, C. G., Magee, J. C., Parker, W. R., and Platt, J. L., Hyperacute rejection of cardiac xenografts between primate species: evidence to support the significance of the α-Galactosyl determinant, J. Immunol., 154, 5500, 1995.
113. Cotterell, A. H., Alvarado, C. G., Logan, J. S., and Platt, J. L., Variation in expression of porcine antigens recognized by human xenoreactive natural antibodies, Transpl. Proc., 27, 278, 1995.
114. Geller, R. L., Rubinstein, P., and Platt, J. L., Variation in expression of porcine xenogeneic antigens, Transplantation, 58, 272, 1994.
115. Alvarado, C. G., Cotterell, A. H., McCurry, K. R., Collins, B. H., Magee, J. C., Berthold, J., Logan, J. S., and Platt, J. L., Variation in the level of xenoantigen expression in porcine organs, Transplantation, 59, 1589, 1995.
116. Lampugnani, M. G., Resnati, M., Dejana, E., and Marchisio, P. C., The role of integrins in the maintenance of endothelial monolayer integrity. J. Cell Biol., 112, 479, 1991.
117. Kornberg, L. J., Earp, H. S., Turner, C. E., Prockop, C., and Juliano, R. L., Signal transduction by integrins: increased protein tyrosine phosphorylation caused by clustering of b1 integrins, Proc. Natl. Acad. Sci. U.S.A., 88, 8392, 1991.
118. Hynes, R. O. Integrins: versatility, modulation, and signaling in cell adhesion, Cell, 69, 11, 1992.
119. Baumgartner, H. R., Tschopp, T. B., and Meyer, D., Shear rate dependent inhibition of platelet adhesion and aggregation on collagenous surfaces by antibodies to human factor VIII/von Willebrand factor, Br. J. Haematol., 44,127, 1980.
120. Turitto, V. T., Weiss, H. J., Zimmerman, T. S., and Sussman, I. I., Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion, Blood, 65,823, 1985.
121. Roth, G. J., Platelets and blood vessels: the adhesion event. Immunol.Today, 13, 100, 1992.
122. Bannett, A. D., McAlack, R. F., Raja, R., Baquero, A., and Morris, M., Experiences with known ABO-mismatched renal transplants, Transpl. Proc., 19,4543, 1987.
123. Cooper, D. K. C., Ye, Y., Niekrasz, M., Kehoe, M., Martin, M., Neethling, F. A., Kosanke, S., DeBault, L. E., Worsley, G., Zuhdi, N., Oriol, R., and Romano, E., Specific intravenous carbohydrate therapy: a new concept in inhibiting antibody-mediated rejection - experience with ABO-incompatible cardiac allografting in the baboon, Transplantation, 56, 769, 1993.
124. Ye, Y., Neethling, F. A., Niekrasz, M., Koren, E., Richards, S. V., Martin, M., Kosanke, S., Oriol, R., and Cooper, D. K. C., Evidence that intravenously administered α-Galactosyl carbohydrates reduce baboon serum cytotoxicity to pig kidney cells (PK15) and transplanted pig hearts, Transplantation, 58, 330, 1994.
125. Dabkowski, P. L., Vaughan, H. A., McKenzie, I. F. C., and Sandrin, M. S., Isolation of a cDNA clone encoding the Pig α1,3 Galactosyltransferase, Transpl. Proc., 26, 1335, 1994.
126. Strahan, K., Gu, F., Andersson, L., and Gustafsson, K., Pig α1,3 galactosyltransferase: sequence of a full length cDNA clone and chromosomal localisation of the corresponding gene, Transpl. Proc., 27, 245, 1995.
127. Sharma, A., Okabe, J. F., Birch, P., Platt, J. L., and Logan, J. S., Expression of α1,2 fucosyltransferases in transgenic animals to reduce the number of Gal α1,3Gal epitopes, Proc. Natl. Acad. Sci. U.S.A., 93, 7190, 1996.
128. Chari, R. S., Collins, B. H., Magee, J. C., Kirk, A. D., Harland, R. C., McCann, R. L., Platt, J. L., and Meyers, W. C., Treatment of hepatic failure with ex vivo pig liver perfusion followed by liver transplantation, N. Eng. J. Med., 331, 234, 1994.
129. Sela, B. A., Wang, J. L., and Edelman, G. M., Antibodies reactive with cell surface carbohydrates, Proc. Natl. Acad. Sci. U.S.A., 72, 1127, 1975.
130. Platt, J. L. and Logan, J. S., The generation and use of transgenic animals for xenotransplantation, in Transgenic Animals: Generation and Use, Houdebine, L. M., Ed., Harwood academic publishers, Amsterdam, in press, 1996.
131. Leventhal, J., Flores, H., Gruber, S., Figueroa, J., Platt, J. L., Manivel, J., Bach, F. H., Matas, A. J., and Bolman, R. M., III, Evidence that 15-deoxyspergualin inhibits natural antibody production but fails to prevent hyperacute rejection in a discordant xenograft model, Transplantation, 54, 26, 1992.
132. Dalmasso, A. P. and Platt, J. L., Prevention of complement-mediated activation of xenogeneic endothelial cells in an in vitro model of xenograft hyperacute rejection by C1 inhibitor, Transplantation, 56, 1171, 1993.
133. Zhao, Z., Termignon, J.-L., Cardoso, J., Chereau, C., Gautreau, C., Calmus, Y., Houssin, D., and Weill, B., Hyperacute xenograft rejection in the swineto-human donor-recipient combination: in vitro analysis of complement activation, Transplantation, 57, 245, 1994.
134. Zhow, X. J., Niesen, N., Pawlowski, I., Biesecker, G., Andres, G., Brentjens, J., and Milgrom, F., Prolongation of survival of discordant kidney xenografts by C6 deficiency, Transplantation, 50,896, 1990.
135. Kroshus, T. J., Rollins, S. A., Dalmasso, A. P., Elliott, E. A., Matis, L. A., Squinto, S. P., and Bolman, R. M., Complement inhibition with an antic5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation, Transplantation, 60, 1194, 1995.
136. Wrenshall, L. E., Platt, J. L., Chopek, M. W., Fischel, R., and Matas, A. J., ABO incompatible transplantation in pigtail macaque monkeys, Transpl. Proc., 23, 703, 1991.
137. Diamond, L. E., McCurry, K. R., Oldham, E. R., McClellan, S. B., Martin, M. J., Platt, J. L., and Logan, J. S., Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium, Transplantation, 61, 1241, 1996.
138. Vercellotti, G. M., Platt, J. L., Bach, F. H., and Dalmasso, A. P., Neutrophil adhesion to xenogeneic endothelium via ic3b, J. Immunol., 146, 730, 1991.
139. Saadi, S., Ihrcke, N. S., and Platt, J. L., Endothelial cell shape and hyperacute rejection, Transpl. Proc., 26, 1149, 1994.
140. Basta, M., Kirshbom, P., Frank, M. M., and Fries, L. F., Mechanism of therapeutic effect on high-dose intravenous immunoglobulin - attenuation of acute, complement-dependent immune damage in a guinea pig model, J. Clin. Invest., 84, 1974, 1989.
141. Magee, J. C., Collins, B. H., Harland, R. C., Bollinger, R. R., Frank, M. M., Platt, J. L., and Lindman, B. J., Immunoglobulin prevents complement mediated hyperacute rejection in swine-to-primate xenotransplan-tation, J. Clin. Invest., 96, 2404, 1995.
142. Saadi, S., Holzkhecht, R. A., Patte, C. P., Stern, D. M., and Platt, J. L., Complement-mediated regulation of tissue factor activity in endothelium, J. Exp. Med., 182, 1807, 1995.
143. Cattell, V. and Jamieson, S. W., Hyperacute rejection of guinea pig-to-rat cardiac xenografts, J. Pathol., 115, 183, 1975.
144. Starzl, T. E., Boehmig, H. J., Amemiya, H., Wilson, C. B., Dixon, F. J., Giles, G. R., Simpson, K. M., and Halgrimson, C. G., Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection, N. Eng. J. Med., 283, 383, 1970.
145. Forbes, R. D. C., Guttmann, R. D., Kuramochi, T., Klassen, J., and Knaack, J., Nonessential role of neutrophils as mediators of hyperacute cardiac allograft rejection in the rat, Lab.Inv., 34, 229, 1976.
146. Zehr, K. J., Herskowitz, A., Lee, P. C., Kumar, P., Gillinov, A. M., and Baumgartner, W. A., Neutrophil adhesion and complement inhibition prolongs survival of cardiac xenografts in discordant species, Transplantation, 57, 900, 1994.
147. Malyguine, A. M., Platt, J. L., Saadi, S., and Dawson, J. R., Human natural killer cells induce morphologic changes in porcine endothelial cell monolayers, Transplantation, 61, 161, 1996.
148. Sachs, D. H. and Sablinski, T., Tolerance across discordant xenogeneic barriers, Xenotransplantation, 2, 234, 1995.
149. Moses, R. D., Pierson, R. N., Winn, H. J., and Auchincloss, H., Xenogeneic proliferation and lymphokine production are dependent on CD4+ helper t cells and self antigen-presenting cells in the mouse, J. Exp. Med., 172, 567, 1990.
150. Irwin, M. J., Heath, W. R., and Sherman, L. A., Species-restricted interactions between CD8 and the α3 domain of class I influence the magnitude of the xenogeneic response, J. Exp. Med., 170, 1091, 1989.
151. Moses, R. D., Winn, H. J., and Auchincloss, H. Jr., Multiple defects in cell surface molecule interactions across species differences are responsible for diminished xenogeneic T cell responses, Transplantation , 53, 203, 1992.
152. Murray, A. G., Khodadoust, M. M., Pober, J. S., and Bothwell, A. L. M., Porcine aortic endothelial cells activate human T cells: Direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28, Immunity, 1, 57, 1994.
153. Ihrcke, N. S., Wrenshall, L. E., Lindman, B. J., and Platt, J. L., Role of heparan sulfate in immune system-blood vessel interactions, Immunol.Today, 14, 500, 1993.
154. Ihrcke, N. S. and Platt, J. L., Shedding of heparan sulfate proteoglycan by stimulated endothelial cells: evidence for proteolysis of cell surface molecules, J. Cell Physiol., in press, 1996.
155. Wrenshall, L. E., Cerra, F. B., Singh, R. K., and Platt, J. L., Heparan sulfate initiates signals in murine macrophages leading to divergent biological outcomes, J. Immunol., 154, 871, 1995.
156. Wrenshall, L. E., Cerra, F. B., Carlson, A., Bach, F. H., and Platt, J. L., Regulation of T lymphocyte responses by heparan sulfate, J. Immunol., 147, 455, 1991.
157. Wrenshall, L. E., Carlson, A., Cerra, F. B., and Platt, J. L., Modulation of cytolytic T-cell responses by heparan sulfate. Transplantation, 57, 1087, 1994.
158. Kanwar, Y. S., Linker, A., and Farquhar, M. G., Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion, J. Cell Biol., 86, 688, 1980.
159. Majno, G. and Palade, G. E., The effect of histamine and serotonin on vascular permeability: an electron microscopic study, J. Biophys. Biochem. Cytol., 11, 571, 1961.
160. Svensjo, E., Arfors, K.-E., Raymond, R. M., and Grega, G. J., Morphological and physiological correlation of bradykinin-induced macromolecular efflux, Am. J. Physiol., 236, 600, 1979.
161. Rosenberg, R. D. and Rosenberg, J. S., Natural anticoagulent mechanisms, J. Clin. Invest., 74, 1, 1984.
162. Esmon, N. L., Owen, W. G., and Esmon, C. T., Isolation of a membrane - bound cofactor for thrombin-catalyzed activation of protein C, .J Biol. Chem., 257, 859, 1982.
163. Palmer, R. M. J., Ferridge, A. G., and Moneada, S., Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor, Nature, 327, 524, 1987.
164. Pinsky, D., Oz, M., Liao, H., Brett, J., Morris, S., Morales, M., Van Lookeren Campagne, M., Karakurum, M., Platt, J. L., Nowygrod, R., Stern, D., and Koga, S., Restoration of the cAMP second messenger pathway enhances cardiac preservation for transplantation in a heterotopic rat model, J. Clin. Invest., 92, 2994, 1993.
165. Hamilton, K. K., Hattori, R., Esmon, C. T., and Sims, P. J., Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex, J. Biol. Chem., 265, 3809, 1990.
166. Hattori, R., Hamilton, K. K., McEver, R. P., and Sims, P. J., Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface, J. Biol. Chem., 264, 9053, 1989.
167. Platt, J. L., Mechanisms of tissue injury in hyperacute xenograft rejection. ASAIO J., 38, 8, 1992.
168. Stevens, R. B., Wang, Y. L., Kaji, H., Lloveras, J., Dalmasso, A. B., Bach, F. H., Rubinstein, P., Sutherland, D. E. R., and Platt, J. L., Administration of nonanticoagulant heparin inhibits the loss of glycosaminoglycans from xenogeneic cardiac grafts and prolongs graft survival, Transpl. Proc., 25, 382, 1993.
169. Key, N. S., Platt, J. L., and Vercellotti, G. M.,. Vascular endothelial cell proteoglycans are susceptible to cleavage by neutrophils, Arterio. Thromb., 12, 836, 1992.
170. van Mourik, J. A., von dem Borne, A. E. G., and Giltay, J. G., Pathophysiological significance on integrin expression by vascular endothelial cells, Biochem. Pharmacol.., 39, 233, 1990.
171. Saadi, S. and Platt, J. L., Transient perturbation of endothelial integrity induced by antibodies and complement, J. Exp. Med., 181, 21, 1995.
172. Stelzner, T. J., Weil, J. V., and O'Brien, R. F., Role of cyclic adenosine monophosphate in the induction of endothelial barrier properties, J. Cell Physiol., 139, 157, 1989.
173. Naito, M., Hayashi, T., Kuzuya, M., Funaki, C., Asai, K., and Kuzuya, F., Vascular endothelial cell migration in vitro roles of cyclic nucleotides, calcium ion and cytoskeletal system, Artery, 17, 21, 1989.
174. McEver, R. P., Beckstead, J. H., Moore, K. L., Marshall-Carlson, L., and Bainton, D. F., GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies, J. Clin. Invest., 84, 92, 1989.
175. Geng, J. G., Bevilacqua, M. P., Moore, K. L., McIntyre, T. M., Prescott, S. M., Kim, J. M., Bliss, G. A., Zimmerman, G. A., and McEver, R. P., Rapid neutrophil adhesion to activated endothelium mediated by GMP-140, Nature, 343, 757, 1990.
176. Hattori, R., Hamilton, K. K., Fugate, R. D., McEver, R. P., and Sims, P. J., Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140, J. Biol. Chem., 264, 7768, 1989.
177. Sims, P. J. and Wiedmer, T., The response of human platelets to activated components of the complement system, Immunol. Today, 12, 338, 1991.
178. Cerra, F. B., Raza, S., Andres, G. A., and Siegel, J. H., The endothelial damage of pulsatile renal preservation and its relationship to perfusion pressure and colloid osmotic pressure, Surgery, 81, 534, 1977.
179. Bannett, A. D., McAlack, R. F., Morris, M., Chopek, M., and Platt, J. L., ABO incompatible renal transplantation: a qualitative analysis of native endothelial tissue ABO antigens after transplant, Transpl. Proc., 21, 783, 1989.
180. Leventhal, J. R., Sakiyalak, P., Witson, J., Simone, P., Matas, A. J., Bolman, R. M., and Dalmasso, A. P., The synergistic effect of combined antibody and complement depletion on discordant cardiac xenograft survival in nonhuman primates, Transplantation, 57, 974, 1994.
181. Thompson, C., Humanised pigs hearts boost xenotransplantation, Lancet, 346, 766, 1995.
182. Busso, N., Huet, S., Nicodeme, E., Hiernaux, J., and Hyafil, F., Refractory period phenomenon in the induction of tissue factor expression on endothelial cells, Blood, 78, 2027, 1991.
183. Shibata, T., Cosio, F. G., and Birmingham, D. J., Complement activation induces the expression of decay-accelerating factor on human mesangial cells, J. Immunol., 147, 3901, 1991.
184. Turman, M. A., Casali, P., Notkins, A. L., Bach, F. H., and Platt, J. L., Polyreactivity and antigen specificity of human xenoreactive monoclonal and serum natural antibodies, Transplantation, 52, 710, 1991.
185. Lachmann, P. J., The control of homologous lysis, Immunol.Today, 12, 312, 1991.
186. Geller, R. L., Bach, F. H., Turman, M. A., Casali, P., and Platt, J. L., Evidence that polyreactive antibodies are deposited in rejected discordant xenografts, Transplantation, 55, 168, 1993.
187. Nowinski, R. C. and Kaehler, S. L., Antibody to leukemia virus: widespread occurrence in inbred mice, Science, 185, 860, 1974.
188. Evans, R.W., Executive Summary. The National Cooperative Transplantation Study, BHARC, Seattle, WA, 1991.
189. DeMasi, R., Alqaisi, M., Araneda, D., Nifong, W., Thomas, J., Gross, U., Swanson, M., and Thomas, F., Reevaluation of total-lymphoid irradiation and cyclosporine therapy in the syrian hamster-to-lewis rat cardiac xenograft model, Transplantation, 49, 639, 1990.
190. Van de Stadt, J., Vendeville, B., Weill, B., Crougneau, S., Michel, A., Filipponi, F., Icard, P., Renoux, M., Louvel, A., and Houssin, D., Discordant heart xenografts in the rat: additional effect of plasma exchange and cyclosporine, cyclophosphamide, or splenectomy in delaying hyperacute rejection, Transplantation, 45, 514, 1988.
191. Ben-Hur, N., Solowey, A. C., and Rapaport, F. T., The xenograft rejection phenomenon. I. Response of the mouse to rabbit, guinea pig and rat skin xenografts, Israel J. Med. Sci., 5, 1, 1969.